ClinicalTrials.Veeva

Menu

The Effect of Mydriatic Eye Drops on Cerebral and Mesenteric Oxygenation in Preterm Infants

Z

Zekai Tahir Burak Women's Health Research and Education Hospital

Status and phase

Unknown
Phase 4

Conditions

Prematurity of Fetus

Treatments

Device: near infrared spectroscopy: invos 5100

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Near infrared spectroscopy offers the possibility of noninvasive and continuous bedside investigation of cerebral and mesenteric oxygenation in newborn infants. Using this technique the investigators investigated the effect of mydriatic eye drops on cerebral and mesenteric oxygenation in preterm infants

Full description

The cerebral and mesenteric oxygenation will be measured by NIRS before, during and after the mydriatic eye drops are instilled.

Enrollment

30 estimated patients

Sex

All

Ages

28 to 90 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. < 32 gestational age and/or < 1500gr.
  2. ≥ 28th day preterm infants
  3. Instilled mydriatic eye drops for ROP examination

Exclusion criteria

  1. Sepsis
  2. Shock
  3. Severe intracranial hemorrhage
  4. NEC
  5. Abdominal and cranial surgery

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Ugur Dilmen, Prof.; Hatice Tatar Aksoy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems